PRPH Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 16:00):

Stats
Today's Volume	99 266.00
Average Volume	49 685.00
Market Cap	94.92M
EPS	$0 ( 2024-03-26 )
Next earnings date	( $-0.410 ) 2024-05-08
Last Dividend	$0.300 ( 2022-05-24 )
Next Dividend	$0 ( N/A )
P/E	-5.37
ATR14	$0.0120 (0.23%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-17	Karkus Ted William	Buy	400 000	Option (right to buy)
2024-01-01	Latkin Jed	Buy	500 000	Option (right to buy)
2024-01-01	Latkin Jed	Buy	0
2024-03-17	Hirsch Warren	Buy	70 000	Option (right to buy)
2024-03-17	Gleckel Louis Md	Buy	70 000	Option (right to buy)

INSIDER POWER
17.55
Last 98 transactions
Buy: 8 777 863 \| Sell: 8 858 292

Volume Correlation

Long: -0.10 (neutral)

Short: 0.05 (neutral)

Signal:(53.396) Neutral

Prophase Labs Inc Correlation

10 Most Positive Correlations
RMCF	0.955
CLFD	0.955
CRON	0.939
CMRX	0.938
EVLO	0.937
BMRA	0.93
PCSA	0.929
ADP	0.928
DRUG	0.926
BFC	0.922

10 Most Negative Correlations
GXII	-0.94
CFFE	-0.933
ARTEU	-0.933
BRIVU	-0.932
TRHC	-0.932
MSAC	-0.929
VHNA	-0.928
AMTBB	-0.927
EMLD	-0.927
ATEC	-0.926

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Prophase Labs Inc Correlation - Currency/Commodity

-0.51
( weak negative )

-0.42
( neutral )

0.00
( neutral )

-0.33
( neutral )

-0.85
( strong negative )

0.24
( neutral )

Prophase Labs Inc Financials

Annual	2023
Revenue:	$44.38M
Gross Profit:	$16.24M (36.59 %)
EPS:	$-0.980

Q4	2023
Revenue:	$3.50M
Gross Profit:	$-3.06M (-87.34 %)
EPS:	$-0.480

Q3	2023
Revenue:	$8.37M
Gross Profit:	$2.33M (27.82 %)
EPS:	$-0.300

Q2	2023
Revenue:	$13.22M
Gross Profit:	$6.45M (48.79 %)
EPS:	$-0.200

Financial Reports:

No articles found.

Prophase Labs Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Prophase Labs Inc Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$1.000	2018-06-06
Last Dividend	$0.300	2022-05-24
Next Dividend	$0	N/A
Payout Date	2022-06-03
Next Payout Date	N/A
# dividends	6	--
Total Paid Out	$2.40	--
Avg. Dividend % Per Year	2.00%	--
Score	1.36	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-11-07)

$0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

1.36

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2018	$1.000	44.60%
2019	$0.500	15.40%
2020	$0	0.00%
2021	$0.300	2.84%
2022	$0.600	8.10%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.378	1.500	-7.56	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.183	1.200	-6.09	-7.30	[0 - 0.3]
returnOnEquityTTM	-0.298	1.500	-4.43	-6.64	[0.1 - 1]
payoutRatioTTM	-0.453	-1.000	-4.53	4.53	[0 - 1]
currentRatioTTM	2.28	0.800	3.59	2.87	[1 - 3]
quickRatioTTM	1.994	0.800	2.98	2.38	[0.8 - 2.5]
cashRatioTTM	0.103	1.500	-0.539	-0.808	[0.2 - 2]
debtRatioTTM	0.142	-1.500	7.63	-10.00	[0 - 0.6]
interestCoverageTTM	-16.95	1.000	-7.39	-7.39	[3 - 30]
operatingCashFlowPerShareTTM	-0.629	2.00	-0.210	-0.419	[0 - 30]
freeCashFlowPerShareTTM	-0.804	2.00	-0.402	-0.804	[0 - 20]
debtEquityRatioTTM	0.264	-1.500	8.94	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.366	1.000	7.24	7.24	[0.2 - 0.8]
operatingProfitMarginTTM	-0.487	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.870	1.000	-5.94	-5.94	[0.2 - 2]
assetTurnoverTTM	0.483	0.800	-0.115	-0.0916	[0.5 - 2]
Total Score				-2.25

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-6.59	1.000	-0.767	0	[1 - 100]
returnOnEquityTTM	-0.298	2.50	-2.85	-6.64	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.804	2.00	-0.268	-0.804	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.629	2.00	-0.210	-0.419	[0 - 30]
payoutRatioTTM	-0.453	1.500	-4.53	4.53	[0 - 1]
pegRatioTTM	-0.124	1.500	-4.16	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.256	1.000	-8.89	0	[0.1 - 0.5]
Total Score				-3.08

Prophase Labs Inc

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab methods; and other respiratory pathogen panel molecular testing services, as well as personal genomics products and services. It serves national chain drug, internet-based, and various regional retailers. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.